Journal of Psychoactive Drugs


Haight Ashbury Publications

Back Issues

Author Guidelines

About Us


Published by Haight Ashbury Publications


California Substance Abuse Research Consortium (SARC) Meeting, Spring 2003


Table of Contents

SARC Supplement, Number 2

May 2004


Editor’s Introduction: California Substance Abuse Research Consortium, Spring 2003 —  Richard Rawson, Ph.D.; Darren Urada, Ph.D. & Beth Finnerty, M.P.H.

California Substance Abuse Research Consortium, May 2003:  Update on Recent Substance Abuse Trends  —  Beth A. Finnerty, M.P.H.

Pilot-Testing a Statewide Outcome Monitoring System:  Overview of the California Treatment Outcome Project (CALTOP) — Elizabeth Evans, M.A. & Yih-Ing Hser, Ph.D.

Diffusion of Substance Abuse Treatment: Will Buprenorphine be a Success?  — Walter Ling, M.D.; Jerry Cunningham-Rathner & Richard Rawson, Ph.D.

Buprenorphine in Treatment of Opiate Dependence:  Its Pharmacology and Social Context of Use in the US — Donald R. Wesson, M.D.

Evolving Use of Buprenorphine in the Treatment of Addiction — Judith Martin, M.D.

Counseling Buprenorphine Patients: Information and Treatment Approaches for Counselors — Michael J. McCann, M.A.

California Drug Courts:  A Methodology for Determining Costs and Avoided Costs — Francine Byrne, M.A.; Richard Schauffler, M.A.; Lisa Lightman, M.A.;  Michael Finigan, Ph.D. & Shannon Carey, Ph.D.

Alcohol and Violence: Connections, Evidence and Possibilities for Prevention — Robert Nash Parker, Ph.D.

Evaluation of the Substance Abuse and Crime Prevention Act:  Treatment Clients and Program Types During the First Year of Implementation — Elizabeth Evans, M.A. & Douglas Longshore, Ph.D.

When You Assume… The Reality of Implementing a Legally Mandated Substance Abuse Treatment Program — Deane Wiley, Ph.D. ; Martha Beattie, Ph.D. ; Hung Nguyen, M.S. ; Katherine Puckett, Ph.D.; Kakoli Banerjee, Ph.D. & Winnie Poon

COVER ART — Continental Divide by Rori Ranch Productions



SARC Supplement No. 2

May 2004

Table of Contents

(downloadable file)



Copyright Journal of Psychoactive Drugs. All Rights Reserved.